The dual GLP-1/GIP receptor activation has proven particularly effective in patients with Type 2 diabetes, where Mounjaro not only improves glycaemic control but also promotes substantial weight loss
Nature , 469 (7328), 172-179
CagriSema data additionally showed anti-inflammatory effects and significant blood pressure reductions in analyses presented at ObesityWeek, suggesting cardiovascular benefits that extend beyond weight loss alone
Weeks 9 to 12: dose-dependent acceleration By weeks 9-12, people on higher doses (8mg or transitioning to 12mg) typically experience the strongest appetite suppression they have felt to date
It is also important to consider the potential for interactions with chemotherapeutic agents
Have they moved away from the behaviors that were helping them lose weight in the first place, like tracking foods? she proposed